Show items per page
Elements: 378
Page 8 on 8
 TitleAuthors / EditorsDate
add to browser selection
Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study Lorenzi, P.; Yerly Ferrillo, Sabine; Abderrakim, K.; Fathi, Marc; ... Hirschel, Bernard 1997
add to browser selection
Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome Renold, C; Sugar, A; Chave, J P; Perrin, Luc; ... Hirschel, Bernard 1992
add to browser selection
Traitement par cidofovir topique d'infections cutanées à papillomavirus humain, poxvirus et Herpes simplex virus chez des malades séropositifs pour le VIH Toutous-Trellu, L.; Hirschel, Bernard; Piguet, Vincent; Schiffer, V.; ... Pechere, Marc 2004
add to browser selection
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study Simcock, Mathew; Blasko, Monika; Karrer, Urs; Bertisch, Barbara; ... Koller, M. T. 2007
add to browser selection
Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study Heald, A.; Flepp, M.; Chave, J. P.; Malinverni, R.; ... Hirschel, Bernard 1991
add to browser selection
Treatment interruption for convenience, cost cutting and toxicity sparing Nuesch, Reto; Hirschel, Bernard 2007
add to browser selection
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008 Elzi, Luigia; Marzolini, Catia; Furrer, Hansjakob; Ledergerber, Bruno; ... Battegay, Manuel 2010
add to browser selection
Tuberculin skin reactivity in HIV-seropositive intravenous drug addicts Robert, C. F.; Hirschel, Bernard; Rochat, Thierry; Déglon, Jean-Jacques 1989
add to browser selection
Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study Group Sudre, Philippe; Hirschel, Bernard; Gatell, J. M.; Schwander, S.; ... Lundgren, J. D. 1996
add to browser selection
Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen Sachsenberg, N.; Perelson, A. S.; Yerly Ferrillo, Sabine; Schockmel, G. A.; ... Perrin, Luc 1998
add to browser selection
Two different 16S rRNA genes in a mycobacterial strain Bescher Ninet, Béatrice Alice; Monod, M.; Emler, Stefan; Pawlowski, Jan Wojciech; ... Hirschel, Bernard 1996
add to browser selection
Typhus abdominalis nach Impfung mit dem Lebend-Impfstoff Vivotif Hirschel, Bernard; Hirschel-Scholz, S.; Luthy, R.; Bonetti, A. 1983
add to browser selection
Typhusepidemiologie in der Schweiz 1980-1983. Geringe oder fehlende Wirksamkeit des Lebendimpfstoffes Vivotif bei Tropenreisenden Wuthrich, R. P.; Somaini, B.; Steffen, R.; Hirschel, Bernard 1985
add to browser selection
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study Rauch, Andri; Rickenbach, Martin; Weber, Rainer; Hirschel, Bernard; ... Furrer, Hansjakob 2005
add to browser selection
Unusual primary HIV infection with colonic ulcer complicated by hemorrhagic shock: a case report Emonet, Stéphane Paul; Dettwiler, Sarah; Der Hagopian, Isabelle; Yerly Ferrillo, Sabine; ... Hirschel, Bernard 2010
add to browser selection
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study Weber, R.; Huber, M.; Rickenbach, M.; Furrer, Hansjakob; ... Ledergerber, Bruno 2009
add to browser selection
VIH – sida Traitement de l'infection à VIH en 2006 : points forts Schiffer, V.; Hirschel, Bernard 2007
add to browser selection
VIH-sida El Amari, E. B.; Hirschel, Bernard 2009
add to browser selection
VIH: épidemiologie et traitement--2000 Telenti, A.; Hirschel, Bernard 2000
add to browser selection
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen Fox, Zoe; Phillips, Andrew; Cohen, Cal; Neuhaus, Jacquie; ... Lundgren, Jens 2008
add to browser selection
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors Scherrer, Alexandra U; von Wyl, Viktor; Böni, Jürg; Yerly Ferrillo, Sabine; ... Günthard, Huldrych F 2011
add to browser selection
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV Young, Jim; Bucher, H. C.; Guenthard, H. F.; Rickenbach, Martin; ... Battegay, Manuel 2009
add to browser selection
Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study, by Matthews et al Hirschel, Bernard 2003
add to browser selection
Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy Perrin, Luc; Yerly Ferrillo, Sabine; Marchal, F.; Schockmel, G. A.; ... Pantaleo, G. 1998
add to browser selection
Vorbeugen ist teurer als heilen Hirschel, Bernard 1985
add to browser selection
Weight-losing HIV-infected patients on recombinant human growth hormone for 12 wk: a national study Cominelli, Silvano; Raguso, C. A.; Karsegard, Laurie; Hirschel, Bernard; ... Pichard, Claude 2002
add to browser selection
Zidovudine plus didanosine in primary HIV-1 infection Perrin, Luc; Yerly Ferrillo, Sabine; Charvier, A.; Figueras, G.; ... Hirschel, Bernard 1997
add to browser selection
Zweitinfektion mit HIV: Mythos oder Realitat? Vernazza, P. L.; Bernasconi, Enos; Hirschel, Bernard 2000
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | next >>